Literature DB >> 3352305

Early and late results of aortic root replacement with antibiotic-sterilized aortic homograft.

Y Okita1, G Franciosi, O Matsuki, A Robles, D N Ross.   

Abstract

Between November 1972 and November 1986, 108 patients aged 5 to 73 years had complete replacement of the aortic root with an aortic homograft into which the coronary arteries were implanted. The main indications were (1) a tunnel type of aortic obstruction involving a hypoplastic ring, (2) a para-aortic annular abscess, (3) prosthetic valve dysfunction, mainly a previous aortic homograft, and (4) aortic stenosis with a small aortic anulus. Eighty-four patients (78%) had previous aortic valve operations. Concomitant cardiac procedures were done in 34 patients (32%). The 30-day mortality rate was 14% (15 patients). The cumulative follow-up period was 180.3 patient-years. The late mortality rate was 6.1% per patient-year (11 patients). The patients were not given anticoagulants postoperatively, but the entire group has been completely free from thromboembolism. The actuarial 5-year survival rate including operative deaths was 72%. The freedom from valve-related death at 5 years after operation is 86% and freedom from reoperation at 5 years is 96%. The use of homografts for replacement of the aortic valve and root in patients with complex lesions affecting these structures has shown encouraging early and late results, with regard to both survival and valve performance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3352305

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  Modified Ross procedure with stentless bioprosthesis and pericardial xenograft for the right ventricular outflow tract. Usefulness of autologous pericardial patch for hemostasis.

Authors:  Hiroya Minami; Noboru Wakita; Takeshi Mimura; Kyozo Inoue; Masahiro Sakata; Yutaka Okita
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-11

2.  [Aortic root replacement by cryopreserved homograft for prosthetic valve detachment case due to aortitis].

Authors:  T Yamamoto; H Makuuchi; Y Naruse; T Kobayashi; M Goto; K Nonaka
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-06

3.  [Mid-term evaluation of cryopreserved aortic allograft].

Authors:  H Machida; K Eishi; S Nakajima; K Nakano; S Takamoto; T Tsuji
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-02

Review 4.  Surgical treatment for aortic periannular abscess/pseudoaneurysm caused by infective endocarditis.

Authors:  Kenji Okada; Yutaka Okita
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-11-17

5.  Bentall operation with valved homograft conduit.

Authors:  S K Choudhary; S Talwar; A S Kumar
Journal:  Tex Heart Inst J       Date:  2000

6.  Bentall procedure using cryopreserved valved aortic homografts: mid- to long-term results.

Authors:  Jan T Christenson; Jorge Sierra; Pedro T Trindade; Didier Dominique; Afksendiyos Kalangos
Journal:  Tex Heart Inst J       Date:  2004

7.  Pseudoaneurysm following aortic homograft: clinical implications?

Authors:  E Oechslin; T Carrel; M Ritter; C Attenhofer; L von Segesser; W Kiowski; M Turina; R Jenni
Journal:  Br Heart J       Date:  1995-12

8.  Calcification of allograft aortic wall in a rat subdermal model. Pathophysiology and inhibition by Al3+ and aminodiphosphonate preincubations.

Authors:  C L Webb; N M Nguyen; F J Schoen; R J Levy
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

9.  Sixteen-year experience with aortic root replacement. Results of 172 operations.

Authors:  N T Kouchoukos; T H Wareing; S F Murphy; J B Perrillo
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

10.  Surgical outcomes and optimal approach to treatment of aortic valve endocarditis with aortic root abscess.

Authors:  William M Harris; Shubhra Sinha; Massimo Caputo; Gianni D Angelini; Eltayeb M Ahmed; Cha Rajakaruna; Umberto Benedetto; Hunaid A Vohra
Journal:  J Card Surg       Date:  2022-04-05       Impact factor: 1.778

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.